Michael D. Wendt
Protein-Protein Interactions as Drug Targets
Shaomeng Wang, Yujun Zhao, Denzil Bernard, Angelo Aguilar, Sanjeev Kumar
Targeting the MDM2-p53 Protein-Protein Interaction for New Cancer Therapeutics
Kurt Deshayes, Jeremy Murray, Domagoj Vucic
The Development of Small-Molecule IAP Antagonists for the Treatment of Cancer
John F. Kadow, David R. Langley, Nicholas A. Meanwell, Michael A. Walker, Kap-Sun Yeung, Richard Pracitto
Protein-Protein Interaction Targets to Inhibit HIV-1 Infection
Andrew B. Mahon, Stephen E. Miller, Stephen T. Joy, Paramjit S. Arora
Rational Design Strategies for Developing Synthetic Inhibitors of Helical Protein Interfaces
Michael D. Wendt
The Discovery of Navitoclax, a Bcl-2 Family Inhibitor
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Vendeur : Brook Bookstore On Demand, Napoli, NA, Italie
Etat : new. Questo è un articolo print on demand. N° de réf. du vendeur b6341472efbcb252c109d3c5477983b9
Quantité disponible : Plus de 20 disponibles
Vendeur : moluna, Greven, Allemagne
Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. In each volume an overview chapter introduces the newcomer to the topic coveredSeries covers hot topics of frontier research summarized by reputed scientists in the fieldReview series is topic relatedMichael D. WendtProtei. N° de réf. du vendeur 5055742
Quantité disponible : Plus de 20 disponibles
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Buch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Michael D. WendtProtein-Protein Interactions as Drug TargetsShaomeng Wang , Yujun Zhao , Denzil Bernard , Angelo Aguilar , Sanjeev KumarTargeting the MDM2-p53 Protein-Protein Interaction for New Cancer Therapeutics Kurt Deshayes , Jeremy Murray , Domagoj VucicThe Development of Small-Molecule IAP Antagonists for the Treatment of Cancer John F. Kadow , David R. Langley , Nicholas A. Meanwell , Michael A. Walker , Kap-Sun Yeung , Richard PracittoProtein-Protein Interaction Targets to Inhibit HIV-1 Infection Nicholas A. Meanwell , David R. LangleyInhibitors of Protein-Protein Interactions in Paramyxovirus Fusion - a Focus on Respiratory Syncytial VirusAndrew B. Mahon , Stephen E. Miller , Stephen T. Joy , Paramjit S. AroraRational Design Strategies for Developing Synthetic Inhibitors of Helical Protein Interfaces Michael D. WendtThe Discovery of Navitoclax, a Bcl-2 Family Inhibitor 280 pp. Englisch. N° de réf. du vendeur 9783642289644
Quantité disponible : 2 disponible(s)
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
Etat : New. In. N° de réf. du vendeur ria9783642289644_new
Quantité disponible : Plus de 20 disponibles
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
Etat : New. N° de réf. du vendeur 17845485-n
Quantité disponible : 15 disponible(s)
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
Etat : As New. Unread book in perfect condition. N° de réf. du vendeur 17845485
Quantité disponible : 15 disponible(s)
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Buch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -Michael D. WendtProtein-Protein Interactions as Drug TargetsShaomeng Wang , Yujun Zhao , Denzil Bernard , Angelo Aguilar , Sanjeev KumarTargeting the MDM2-p53 Protein-Protein Interaction for New Cancer TherapeuticsKurt Deshayes , Jeremy Murray , Domagoj VucicThe Development of Small-Molecule IAP Antagonists for the Treatment of CancerJohn F. Kadow , David R. Langley , Nicholas A. Meanwell , Michael A. Walker , Kap-Sun Yeung , Richard PracittoProtein-Protein Interaction Targets to Inhibit HIV-1 InfectionNicholas A. Meanwell , David R. LangleyInhibitors of Protein-Protein Interactions in Paramyxovirus Fusion ¿ a Focus on Respiratory Syncytial VirusAndrew B. Mahon , Stephen E. Miller , Stephen T. Joy , Paramjit S. AroraRational Design Strategies for Developing Synthetic Inhibitors of Helical Protein InterfacesMichael D. WendtThe Discovery of Navitoclax, a Bcl-2 Family InhibitorSpringer-Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 280 pp. Englisch. N° de réf. du vendeur 9783642289644
Quantité disponible : 1 disponible(s)
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Buch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - Michael D. WendtProtein-Protein Interactions as Drug TargetsShaomeng Wang , Yujun Zhao , Denzil Bernard , Angelo Aguilar , Sanjeev KumarTargeting the MDM2-p53 Protein-Protein Interaction for New Cancer Therapeutics Kurt Deshayes , Jeremy Murray , Domagoj VucicThe Development of Small-Molecule IAP Antagonists for the Treatment of Cancer John F. Kadow , David R. Langley , Nicholas A. Meanwell , Michael A. Walker , Kap-Sun Yeung , Richard PracittoProtein-Protein Interaction Targets to Inhibit HIV-1 Infection Nicholas A. Meanwell , David R. LangleyInhibitors of Protein-Protein Interactions in Paramyxovirus Fusion - a Focus on Respiratory Syncytial VirusAndrew B. Mahon , Stephen E. Miller , Stephen T. Joy , Paramjit S. AroraRational Design Strategies for Developing Synthetic Inhibitors of Helical Protein Interfaces Michael D. WendtThe Discovery of Navitoclax, a Bcl-2 Family Inhibitor. N° de réf. du vendeur 9783642289644
Quantité disponible : 1 disponible(s)
Vendeur : Revaluation Books, Exeter, Royaume-Uni
Hardcover. Etat : Brand New. 2012 edition. 285 pages. 9.00x6.25x0.75 inches. In Stock. N° de réf. du vendeur x-3642289649
Quantité disponible : 2 disponible(s)